Bieś, R.; Krzystanek, M.; Górski, M.; Koźmin-Burzyńska, A.; Warchala, A.; Trędzbor, B.; Martyniak, E.; Fojcik, J.
Bromocriptine, Selegiline and Amantadine in the Treatment of Depression—A Systematic Review. Pharmaceuticals 2025, 18, 1664.
https://doi.org/10.3390/ph18111664
AMA Style
Bieś R, Krzystanek M, Górski M, Koźmin-Burzyńska A, Warchala A, Trędzbor B, Martyniak E, Fojcik J.
Bromocriptine, Selegiline and Amantadine in the Treatment of Depression—A Systematic Review. Pharmaceuticals. 2025; 18(11):1664.
https://doi.org/10.3390/ph18111664
Chicago/Turabian Style
Bieś, Rafał, Marek Krzystanek, Michał Górski, Agnieszka Koźmin-Burzyńska, Anna Warchala, Beata Trędzbor, Ewa Martyniak, and Joanna Fojcik.
2025. "Bromocriptine, Selegiline and Amantadine in the Treatment of Depression—A Systematic Review" Pharmaceuticals 18, no. 11: 1664.
https://doi.org/10.3390/ph18111664
APA Style
Bieś, R., Krzystanek, M., Górski, M., Koźmin-Burzyńska, A., Warchala, A., Trędzbor, B., Martyniak, E., & Fojcik, J.
(2025). Bromocriptine, Selegiline and Amantadine in the Treatment of Depression—A Systematic Review. Pharmaceuticals, 18(11), 1664.
https://doi.org/10.3390/ph18111664